Eloralintide: Trial Results, Phase 3 Status
Eloralintide: where it is in development, what the trials show so far, and when it could reach patients.
Eloralintide at a glance
Share of body weight lost at 48 weeks, highest end of the range (Phase 2, vs 0.4% placebo).
Sources: prnewswire.com.